Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - sitagliptin hydrochloride monohydrate - filmtablette - 100 mg - sitagliptin hydrochloride monohydrate 113.37 mg - sitagliptin

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

heumann pharma gmbh & co. generica kg (8120809) - sitagliptinhydrochlorid 1 h<2>o; metforminhydrochlorid - filmtablette - 50 mg/850 mg - sitagliptinhydrochlorid 1 h<2>o (43765) 56,687 milligramm; metforminhydrochlorid (06150) 850 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

heumann pharma gmbh & co. generica kg (8120809) - sitagliptinhydrochlorid 1 h<2>o; metforminhydrochlorid - filmtablette - 50 mg/1000 mg - sitagliptinhydrochlorid 1 h<2>o (43765) 56,687 milligramm; metforminhydrochlorid (6150) 1000 milligramm

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - sitagliptin hydrochloride - filmtablette - 25 mg - sitagliptin hydrochloride 27.238 mg - sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - sitagliptin hydrochloride - filmtablette - 50 mg - sitagliptin hydrochloride 54.475 mg - sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - sitagliptin hydrochloride - filmtablette - 100 mg - sitagliptin hydrochloride 108.95 mg - sitagliptin

Europäische Union - Deutsch - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

as grindeks - sitagliptin hydrochloride monohydrate - filmtablette - 25 mg - sitagliptin hydrochloride monohydrate 28.35 mg - sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

as grindeks - sitagliptin hydrochloride monohydrate - filmtablette - 50 mg - sitagliptin hydrochloride monohydrate 56.7 mg - sitagliptin

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

as grindeks - sitagliptin hydrochloride monohydrate - filmtablette - 100 mg - sitagliptin hydrochloride monohydrate 113.4 mg - sitagliptin